|
1MK3
SOLUTION STRUCTURE OF HUMAN BCL-W PROTEIN
Deposited 2002-08-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–171(170 aa)
|
Mutation:P116V
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7.3;298 K;Ionic strength (raw mmCIF value) 10 mM NaCl;Pressure 1
NMR sample composition
1.4 mM Bcl-w protein U-15N,13C, 20 mM phosphate buffer | 90% H2O/10% D2O
NMR sample composition
1.3 mM Bcl-w protein U-15N, 20 mM phosphate buffer | 90% H2O/10% D2O
NMR sample composition
0.5 mM Bcl-w protein U-15N, 6 MG/ML PF1-PHAGE | 90% H2O/10% D2O
|
Resolution not provided
|
|
1O0L
THE STRUCTURE OF BCL-W REVEALS A ROLE FOR THE C-TERMINAL RESIDUES IN MODULATING BIOLOGICAL ACTIVITY
Deposited 2003-02-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–183(183 aa)
|
Mutation:A128E
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6.7;303.15 K;Ionic strength (raw mmCIF value) 120mM;Pressure ambient
NMR measurement conditions
pH 6.7;303.15 K;Ionic strength (raw mmCIF value) 120mM;Pressure ambient
NMR measurement conditions
pH 6.7;303.15 K;Ionic strength (raw mmCIF value) 120mM;Pressure ambient
NMR sample composition
1 mM Bcl-w | 50mM Sodium Phosphate, 70mM NaCl, 2mM TCEP, 95% H2O, 5% D2O
NMR sample composition
1 mM, U-15N Bcl-w | 50mM Sodium Phosphate, 70mM NaCl, 2mM TCEP, 95% H2O, 5% D2O
NMR sample composition
1 mM, U-13C, 15N, Bcl-w | 50mM Sodium Phosphate, 70mM NaCl, 2mM TCEP, 95% H2O, 5% D2O
|
Resolution not provided
|
|
1ZY3
Structural model of complex of Bcl-w protein with Bid BH3-peptide
Deposited 2005-06-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
2–171(170 aa)
Fragment:residues 2-171
|
Mutation:P116V
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7;303 K;Ionic strength (raw mmCIF value) 10 mM NaCl;Pressure 1
NMR sample composition
0.7 mM Bcl-w U-15N,13C, 0.7 mM Bid BH3-peptide, 20 mM phosphate buffer, 90% H2O, 10% D2O | 90% H2O/10% D2O
NMR sample composition
0.7 mM Bcl-w U-15N, 0.7 mM Bid BH3-peptide, 20 mM phosphate buffer, 90% H2O, 10% D2O | 90% H2O/10% D2O
NMR sample composition
0.7 mM Bid BH3-peptide U-15N, 0.7 mM Bcl-w, 20 mM phosphate buffer, 90% H2O, 10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
2Y6W
Structure of a Bcl-w dimer
Deposited 2011-01-27
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–164(164 aa)
Fragment:C-TERMINAL TRUNCATION, RESIDUES 1-164
Chain B
1–164(164 aa)
Fragment:C-TERMINAL TRUNCATION, RESIDUES 1-164
|
Mutation:YES
Mutation:YES
|
PEG DI(HYDROXYETHYL)ETHER × 5
PGE TRIETHYLENE GLYCOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.5;5% (W/V) PEG 3000, 40% (W/V) PEG 400, 0.1M MES PH 6.5.
|
Resolution 2.00 Å
R-free 0.244
|